OTC Markets OTCQB - Delayed Quote USD

Evofem Biosciences, Inc. (EVFM)

Compare
0.0100
+0.0002
+(2.04%)
At close: January 31 at 3:00:00 PM EST
All numbers in thousands
Breakdown
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Assets
10,554.0000
25,163.0000
42,512.0000
109,968.0000
Total Liabilities Net Minority Interest
77,064.0000
96,963.0000
142,087.0000
108,621.0000
Total Equity Gross Minority Interest
-66,510.0000
-71,800.0000
-99,575.0000
1,347.0000
Total Capitalization
-66,510.0000
-71,800.0000
-99,575.0000
26,558.0000
Preferred Stock Equity
--
--
4,740.0000
--
Common Stock Equity
-66,510.0000
-71,800.0000
-104,315.0000
1,347.0000
Capital Lease Obligations
105.0000
5,444.0000
6,756.0000
8,320.0000
Net Tangible Assets
-66,510.0000
-71,800.0000
-99,575.0000
1,347.0000
Working Capital
-63,253.0000
-81,131.0000
-107,523.0000
20,447.0000
Invested Capital
-23,242.0000
-6,116.0000
4,611.0000
78,967.0000
Tangible Book Value
-66,510.0000
-71,800.0000
-104,315.0000
1,347.0000
Total Debt
43,373.0000
71,128.0000
115,682.0000
85,940.0000
Net Debt
43,268.0000
62,915.0000
101,194.0000
28,728.0000
Share Issued
20,007.7990
984.7860
86.6670
43.3870
Ordinary Shares Number
20,007.7990
984.7860
86.6670
43.3870
12/31/2020 - 11/20/2014

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers